Click for best price
Postpemic Era Companion Animal Drugs Market Size, Share 2022
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
(Post-pandemic Era)-Global Companion Animal Drugs Market Segment Research Report 2022?, which aims to sort out the development status and trends of the Companion Animal Drugs industry at home and abroad, estimate the overall market scale of the Companion Animal Drugs industry and the market share of major countries, Companion Animal Drugs industry, and study and judge the downstream market demand of Companion Animal Drugs through systematic research, Analyze the competition pattern of Companion Animal Drugs, so as to help solve the pain points of various stakeholders in Companion Animal Drugs industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Companion Animal Drugs Market by Research Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Companion Animal Drugs Market?
Zoetis
Bayer
Boehringer Ingelheim
Eli Lilly
Merck
Vetoquinol
Virbac
Dechra Pharmaceuticals
Ceva Sante Animale
Aratana Therapeutics
Major Type of Companion Animal Drugs Covered in Research report:
Antibiotics and Antimicrobials
Parasiticides
Others
Application Segments Covered in Research Market
Dogs
Cats
Horses
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
| Report Attributes |
Report Details |
| Report Title |
(Post-pandemic Era)-Global Companion Animal Drugs Market Segment Research Report 2022 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
86 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
Table of Contents
Global Companion Animal Drugs Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Companion Animal Drugs Market by Value
2.2.1 Global Companion Animal Drugs Revenue by Type
2.2.2 Global Companion Animal Drugs Market by Value
2.3 Global Companion Animal Drugs Market by Sales
2.3.1 Global Companion Animal Drugs Sales by Type
2.3.2 Global Companion Animal Drugs Market by Sales
3. The Major Driver of Companion Animal Drugs Industry
3.1 Historical & Forecast Global Companion Animal Drugs Sales and Revenue (2018-2028)
3.2 Largest Application for Companion Animal Drugs (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Companion Animal Drugs Market
4.1 Regional Market Size in Terms of Sales (2022 & 2028)
4.2 Regional Market Share in Terms of Revenue (2022 & 2028)
4.3 Concentration Ratio (CR5& CR10) of Companion Animal Drugs Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Companion Animal Drugs Sales (2018-2028)
5.1 Current and Estimated Sales Breakdown by Type (2018-2028)
5.2 Current and Estimated Sales Breakdown by Application (2018-2028)
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Companion Animal Drugs Sales (2018-2028)
6.1 Current and Estimated Sales Breakdown by Type (2018-2028)
6.2 Current and Estimated Sales Breakdown by Application (2018-2028)
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Companion Animal Drugs Sales (2018-2028)
7.1 Current and Estimated Sales Breakdown by Type (2018-2028)
7.2 Current and Estimated Sales Breakdown by Application (2018-2028)
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Companion Animal Drugs Sales (2018-2028)
8.1 Current and Estimated Sales Breakdown by Type (2018-2028)
8.2 Current and Estimated Sales Breakdown by Application (2018-2028)
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Companion Animal Drugs Sales (2018-2028)
9.1 Current and Estimated Sales Breakdown by Type (2018-2028)
9.2 Current and Estimated Sales Breakdown by Application (2018-2028)
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Companion Animal Drugs Sales (2018-2028)
10.1 Current and Estimated Sales Breakdown by Type (2018-2028)
10.2 Current and Estimated Sales Breakdown by Application (2018-2028)
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Companion Animal Drugs Sales (2018-2028)
11.1 Current and Estimated Sales Breakdown by Type (2018-2028)
11.2 Current and Estimated Sales Breakdown by Application (2018-2028)
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. South America Companion Animal Drugs Sales (2018-2028)
12.1 Current and Estimated Sales Breakdown by Type (2018-2028)
12.2 Current and Estimated Sales Breakdown by Application (2018-2028)
12.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
12.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
13. Global Companion Animal Drugs Average Price Trend
13.1 Market Price for Each Type of Companion Animal Drugs in US (2018-2022)
13.2 Market Price for Each Type of Companion Animal Drugs in Europe (2018-2022)
13.3 Market Price for Each Type of Companion Animal Drugs in China (2018-2022)
13.4 Market Price for Each Type of Companion Animal Drugs in Japan (2018-2022)
13.5 Market Price for Each Type of Companion Animal Drugs in India (2018-2022)
13.6 Market Price for Each Type of Companion Animal Drugs in Korea (2018-2022)
13.7 Market Price for Each Type of Companion Animal Drugs in Southeast Asia (2018-2022)
13.8 Market Price for Each Type of Companion Animal Drugs in South America (2018-2022)
14. Industrial Chain (Impact of COVID-19)
14.1 Companion Animal Drugs Industrial Chain Analysis
14.2 Downstream
14.3 Impact of COVID-19
14.4 Post-pandemic Era
14.5 Technology Trends of Companion Animal Drugs
15. Companion Animal Drugs Competitive Landscape
15.1 Zoetis
15.1.1 Zoetis Company Profiles
15.1.2 Zoetis Product Introduction
15.1.3 Zoetis Companion Animal Drugs Sales, Revenue (2018-2022)
15.1.4 Strategic initiatives
15.2 Bayer
15.2.1 Bayer Company Profiles
15.2.2 Bayer Product Introduction
15.2.3 Bayer Companion Animal Drugs Sales, Revenue (2018-2022)
15.2.4 Strategic initiatives
15.3 Boehringer Ingelheim
15.3.1 Boehringer Ingelheim Company Profiles
15.3.2 Boehringer Ingelheim Product Introduction
15.3.3 Boehringer Ingelheim Companion Animal Drugs Sales, Revenue (2018-2022)
15.3.4 Strategic initiatives
15.4 Eli Lilly
15.4.1 Eli Lilly Company Profiles
15.4.2 Eli Lilly Product Introduction
15.4.3 Eli Lilly Companion Animal Drugs Sales, Revenue (2018-2022)
15.4.4 Strategic initiatives
15.5 Merck
15.5.1 Merck Company Profiles
15.5.2 Merck Product Introduction
15.5.3 Merck Companion Animal Drugs Sales, Revenue (2018-2022)
15.5.4 Strategic initiatives
15.6 Vetoquinol
15.6.1 Vetoquinol Company Profiles
15.6.2 Vetoquinol Product Introduction
15.6.3 Vetoquinol Companion Animal Drugs Sales, Revenue (2018-2022)
15.6.4 Strategic initiatives
15.7 Virbac
15.7.1 Virbac Company Profiles
15.7.2 Virbac Product Introduction
15.7.3 Virbac Companion Animal Drugs Sales, Revenue (2018-2022)
15.7.4 Strategic initiatives
15.8 Dechra Pharmaceuticals
15.8.1 Dechra Pharmaceuticals Company Profiles
15.8.2 Dechra Pharmaceuticals Product Introduction
15.8.3 Dechra Pharmaceuticals Companion Animal Drugs Sales, Revenue (2018-2022)
15.8.4 Strategic initiatives
15.9 Ceva Sante Animale
15.9.1 Ceva Sante Animale Company Profiles
15.9.2 Ceva Sante Animale Product Introduction
15.9.3 Ceva Sante Animale Companion Animal Drugs Sales, Revenue (2018-2022)
15.9.4 Strategic initiatives
15.10 Aratana Therapeutics
15.10.1 Aratana Therapeutics Company Profiles
15.10.2 Aratana Therapeutics Product Introduction
15.10.3 Aratana Therapeutics Companion Animal Drugs Sales, Revenue (2018-2022)
15.10.4 Strategic initiatives
16. Conclusion
17. Methodology and Data Source
LIST OF TABLES & FIGURES
List of Tables and Figures
Figure 1. Total Sales by Application of Companion Animal Drugs Industry (Volume)
Figure 2. Companion Animal Drugs Sales by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2028)
Figure 4. The Top 10 and 5 Players Market Share by Companion Animal Drugs Revenue in 2022
Figure 5. US Companion Animal Drugs Sales (2018-2028)
Figure 6. Sales Breakdown by Type (%)
Figure 7. Sales Breakdown by Type (%)
Figure 8. Sales Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Companion Animal Drugs Sales (2018-2028)
Figure 12. Sales Breakdown by Type (%)
Figure 13. Sales Breakdown by Type (%)
Figure 14. Sales Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Companion Animal Drugs Sales (2018-2028)
Figure 18. Sales Breakdown by Type (%)
Figure 19. Sales Breakdown by Type (%)
Figure 20. Sales Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Companion Animal Drugs Sales (2018-2028)
Figure 25. Sales Breakdown by Type (%)
Figure 26. Sales Breakdown by Type (%)
Figure 27. Sales Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Companion Animal Drugs Sales (2018-2028)
Figure 31. Sales Breakdown by Type (%)
Figure 32. Sales Breakdown by Type (%)
Figure 33. Sales Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Companion Animal Drugs Sales (2018-2028)
Figure 37. Sales Breakdown by Type (%)
Figure 38. Sales Breakdown by Type (%)
Figure 39. Sales Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Companion Animal Drugs Sales (2018-2028)
Figure 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Figure 44. Sales Breakdown by Type (%)
Figure 45. Sales Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Companion Animal Drugs Revenue, by Type (Million USD) (2018-2028)
Table 4. Companion Animal Drugs Sales, by Type (K Unit) (2018-2028)
Table 5. Companion Animal Drugs Sales (K Unit) by Application (2018-2028)
Table 6. Companion Animal Drugs Sales (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Sales (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2028)
Table 10. Ranking of Global Top Companion Animal Drugs Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Companion Animal Drugs Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 13. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 14. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 15. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Companion Animal Drugs Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 19. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 20. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 21. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Companion Animal Drugs Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 25. Table Current and Estimated Sales Breakdown by Type
Table 26. Current and Estimated Sales Breakdown by Type
Table 27. Current and Estimated Sales Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Companion Animal Drugs Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 30. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 31. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 32. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Companion Animal Drugs Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 36. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 37. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 38. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Companion Animal Drugs Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 42. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 44. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Companion Animal Drugs Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 48. Table Current and Estimated Sales Breakdown by Type (2018-2028)
Table 49. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Companion Animal Drugs in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Companion Animal Drugs in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Companion Animal Drugs in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Companion Animal Drugs in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Companion Animal Drugs in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Companion Animal Drugs in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Companion Animal Drugs in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Zoetis Profiles
Table 61. Zoetis Companion Animal Drugs Product Introduction
Table 62. Zoetis Companion Animal Drugs Sales (Unit), Revenue (Million USD) (2018-2022)
Table 63. Zoetis Strategic initiatives
Table 64. Bayer Profiles
Table 65. Bayer Companion Animal Drugs Product Introduction
Table 66. Bayer Companion Animal Drugs Sales (Unit), Revenue (Million USD) (2018-2022)
Table 67. Bayer Strategic initiatives
Table 68. Boehringer Ingelheim Profiles
Table 69. Boehringer Ingelheim Companion Animal Drugs Product Introduction
Table 70. Boehringer Ingelheim Companion Animal Drugs Sales (Unit), Revenue (Million USD) (2018-2022)
Table 71. Boehringer Ingelheim Strategic initiatives
Table 72. Eli Lilly Profiles
Table 73. Eli Lilly Companion Animal Drugs Product Introduction
Table 74. Eli Lilly Companion Animal Drugs Sales (Unit), Revenue (Million USD) (2018-2022)
Table 75. Eli Lilly Strategic initiatives
Table 76. Merck Profiles
Table 77. Merck Companion Animal Drugs Product Introduction
Table 78. Merck Companion Animal Drugs Sales (Unit), Revenue (Million USD) (2018-2022)
Table 79. Merck Strategic initiatives
Table 80. Vetoquinol Profiles
Table 81. Vetoquinol Companion Animal Drugs Product Introduction
Table 82. Vetoquinol Companion Animal Drugs Sales (Unit), Revenue (Million USD) (2018-2022)
Table 83. Vetoquinol Strategic initiatives
Table 84. Virbac Profiles
Table 85. Virbac Companion Animal Drugs Product Introduction
Table 86. Virbac Companion Animal Drugs Sales (Unit), Revenue (Million USD) (2018-2022)
Table 87. Virbac Strategic initiatives
Table 88. Dechra Pharmaceuticals Profiles
Table 89. Dechra Pharmaceuticals Companion Animal Drugs Product Introduction
Table 90. Dechra Pharmaceuticals Companion Animal Drugs Sales (Unit), Revenue (Million USD) (2018-2022)
Table 91. Dechra Pharmaceuticals Strategic initiatives
Table 92. Ceva Sante Animale Profiles
Table 93. Ceva Sante Animale Companion Animal Drugs Product Introduction
Table 94. Ceva Sante Animale Companion Animal Drugs Sales (Unit), Revenue (Million USD) (2018-2022)
Table 95. Ceva Sante Animale Strategic initiatives
Table 97. Aratana Therapeutics Profiles
Table 98. Aratana Therapeutics Companion Animal Drugs Product Introduction
Table 99. Aratana Therapeutics Companion Animal Drugs Sales (Unit), Revenue (Million USD) (2018-2022)
Table 100. Aratana Therapeutics Strategic initiatives
